NCT07657104 Developing and Implementing HPV SCREENED
| NCT ID | NCT07657104 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Rutgers, The State University of New Jersey |
| Condition | Cervical Cancer Screening |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2026-10-15 |
| Primary Completion | 2027-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2026-10-15 with a primary completion date of 2027-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study will assess the feasibility of implementing HPV self-sampling as a primary cervical cancer screening strategy for under-screened women in the emergency department (ED). Eligible participants will receive education and an HPV self-sampling kit to complete in the ED. Individuals with HPV-positive results will be guided to follow-up care at a local clinic.
Eligibility Criteria
Inclusion Criteria: * biological women, * no prior hysterectomy or cervical cancer, * not pregnant, * last Pap \>3 years, last co-test \>5 years, or last HPV alone test \>5 years, * speak English or Spanish, * has a working cellphone, * NJ residency * ED patient Exclusion Criteria: * currently pregnant (as diagnostic procedures for cervical cancer are often deferred during pregnancy); * previous hysterectomy; * previous diagnosis of cervical cancer; * current menses
Contact & Investigator
Sara Heinert, PhD, MPH
PRINCIPAL INVESTIGATOR
Department of Emergency Medicine, Rutgers Robert Wood Johnson Medical School
Frequently Asked Questions
Who can join the NCT07657104 clinical trial?
This trial is open to female participants only, aged 30 Years or older, up to 65 Years, studying Cervical Cancer Screening. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07657104 currently recruiting?
Yes, NCT07657104 is actively recruiting participants. Contact the research team at sara.heinert@rutgers.edu for enrollment information.
Where is the NCT07657104 trial being conducted?
This trial is being conducted at New Brunswick, United States, Newark, United States.
Who is sponsoring the NCT07657104 clinical trial?
NCT07657104 is sponsored by Rutgers, The State University of New Jersey. The principal investigator is Sara Heinert, PhD, MPH at Department of Emergency Medicine, Rutgers Robert Wood Johnson Medical School. The trial plans to enroll 100 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.